Medical Communications

Showing 15 posts of 6402 posts found.

Laura Steele appointed President and General Manager for Lilly UK

August 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Eli Lilly and Company have announced that Laura Steele has been appointed President and General Manager (GM) for UK, Ireland …

Medical cannabis: The next innovation in oncology?

August 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The market for medical cannabis has been growing steadily over the last decade, but it may be on the cusp …
drugcosts-edt-jumbo

Pharma disputes, fines, and the work of the CMA

August 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Several pharmaceutical firms have lately been fined for unfairly hiking prices over the years, meaning that patients and the NHS …

Acting FDA Chief ruled out as permanent nominee

August 20, 2021 Medical Communications

The administration for US President, Joe Biden, has ruled out nominating Janet Woodcock as permanent head of the FDA, it …
roche__tree

UK approves “first of its kind” antibody cocktail for COVID-19

August 20, 2021 Medical Communications

The MHRA has approved a “first of its kind” antibody cocktail developed by Regeneron and Roche to prevent and treat …

UK COVID booster plan for over 50s may be scrapped

August 20, 2021 Medical Communications

Plans for a mass rollout of booster COVID vaccines for the over 50s this autumn may be shelved as the …

NICE broadens sapropterin guidance for treating phenylketonuria

August 20, 2021 Medical Communications

NICE has extended its approval of sapropterin (also called Kuvan and made by BioMarin) to pregnant women and people aged …

EU approves roxadustat for anaemia associated with chronic kidney disease

August 20, 2021 Medical Communications

Europe has approved Evrenzo (roxadustat) for patients with anaemia associated with symptomatic chronic kidney disease. Evrenzo is the first orally …

President Joe Biden calls for lower prescription drug costs

August 13, 2021 Medical Communications

President Joe Biden has called on congress to take steps to lower prescription drug costs. This would also include allowing …
shutterstock_254160583

$14.4 million: UnitedHealth Group settles charges of illegally denying coverage to patients

August 13, 2021 Medical Communications

The largest US health insurer, UnitedHealth Group, has settles federal and New York state charges of illegally denying coverage to …

FDA authorises third shot of Pfizer or Moderna for immunocompromised

August 13, 2021 Medical Communications

The FDA has authorised a third shot of the Pfizer or Moderna COVID-19 vaccine for some people with weakened immune …

CMA to investigate travel PCR test companies over alleged pricing misconduct

August 13, 2021 Medical Communications

Britain’s competition watchdog, the Competition and Markets Authority (CMA), has announced that it will help the government take action against …

FDA approves new indication for chronic sleep disorder

August 13, 2021 Medical Communications

The FDA has approved a new indication for Xywav for idiopathic hypersomnia (IH) in adults. IH is an uncommon chronic …

Sputnik V vaccine 13% less effective against Delta than originally reported

August 11, 2021 Medical Communications, Research and Development

Russian health officials have announced that the Sputnik V COVID vaccine is 83% effective against the Delta variant on Wednesday, …
laboratory-testing-az

Researchers develop injectable hydrogel to combat Parkinson’s

August 10, 2021 Medical Communications, Research and Development

An Australian research team has developed a hydrogel that can be used as a one-off intervention to treat Parkinson’s disease, …
The Gateway to Local Adoption Series

Latest content